Year |
Citation |
Score |
2012 |
Kusao IK, Troelstrup DL, Agsalda MA, Shiramizu BT. Effective use of small-interfering RNA to characterize residual B-cell non-Hodgkin lymphoma cells following chemotherapy. Journal of Hematological Malignancies. 2: 5-12. PMID 23125882 DOI: 10.5430/jhm.v2n1p5 |
0.703 |
|
2012 |
Kusao I, Shiramizu B, Liang CY, Grove J, Agsalda M, Troelstrup D, Velasco VN, Marshall A, Whitenack N, Shikuma C, Valcour V. Cognitive performance related to HIV-1-infected monocytes. The Journal of Neuropsychiatry and Clinical Neurosciences. 24: 71-80. PMID 22450616 DOI: 10.1176/Appi.Neuropsych.11050109 |
0.645 |
|
2011 |
Shiramizu B, Goldman S, Kusao I, Agsalda M, Lynch J, Smith L, Harrison L, Morris E, Gross TG, Sanger W, Perkins S, Cairo MS. Minimal disease assessment in the treatment of children and adolescents with intermediate-risk (Stage III/IV) B-cell non-Hodgkin lymphoma: a children's oncology group report. British Journal of Haematology. 153: 758-63. PMID 21496005 DOI: 10.1111/J.1365-2141.2011.08681.X |
0.692 |
|
2010 |
Egan K, Kusao I, Troelstrup D, Agsalda M, Shiramizu B. Mitochondrial DNA in residual leukemia cells in cerebrospinal fluid in children with acute lymphoblastic leukemia. Journal of Clinical Medicine Research. 2: 225-9. PMID 21331151 DOI: 10.4021/Jocmr443W |
0.698 |
|
2009 |
Agsalda M, Kusao I, Troelstrup D, Shiramizu B. Screening for residual disease in pediatric burkitt lymphoma using consensus primer pools. Advances in Hematology. 2009: 412163. PMID 19890467 DOI: 10.1155/2009/412163 |
0.684 |
|
2008 |
Kusao I, Troelstrup D, Shiramizu B. Possible Mitochondria-Associated Enzymatic Role in Non-Hodgkin Lymphoma Residual Disease. Cancer Growth and Metastasis. 1: 3-8. PMID 19936279 |
0.661 |
|
2008 |
Kusao I, Agsalda M, Troelstrup D, Villanueva N, Shiramizu B. Chemotoxicity recovery of mitochondria in non-Hodgkin lymphoma resulting in minimal residual disease. Pediatric Blood & Cancer. 51: 193-7. PMID 18322926 DOI: 10.1002/Pbc.21545 |
0.714 |
|
Show low-probability matches. |